In the present study, we confirmed that MSC-EXO and anti-miR17-5p promoted liver repair by inhibiting the activation of LX2 cells, alleviating liver inflammation, and reducing collagen and α-SMA deposition. Here, ACTA1 is linked to medical procedure.